Roxo, The FedEx SameDay Bot, has been busy! The delivery bot recently completed its most advanced set of trials yet in Manchester, New Hampshire. Further development and tests are being scheduled for test delivery of retail items. Check out Roxo in action!
Innovation is vital for a business to establish a competitive advantage. Putting it to work is another challenge in itself, however, and success often comes only after a protracted period of trial and error.
Take CLP’s digital solutions platformSmart Energy Connect (SEC) as an example. Its ability to rebound from the setbacks it encountered in offering an indoor air quality solution provides a useful lesson in the value of persistence.
Where to Focus, Common Challenges & Consequences of Non-Compliance
Blog
In these "new normal" days, environmental, health and safety (EHS) compliance isn’t the sole concern of most businesses—it’s just one part of running a healthy and productive company. But compliance is still an absolute must in order to run a safe and effective business, and EHS managers are faced with the daunting task of managing regulatory compliance across multiple facilities and functions, often without a lot of resources and now likely virtual in some capacity. As we look at this new year, it's a great time to refocus and revisit your "pre-COVID" initiatives and goals.
You'll now be able to upload and validate COVID-19 test results, review local entry requirements, find testing providers and store vaccination records all in the "My Trips" section of the United app or website.
Défi TD Prêts à agir 2020 : 10 millions de dollars canadiens en subventions remis à des organismes proposant des solutions novatrices pour aider à relever les défis liés à la COVID-19
Press Release
TORONTO, le 29 janv. 2021 /3BL Media/ - Aujourd'hui, la TD est fière de remettre 10 millions de dollars canadiens en subventions à 15 organismes nord-américains qui s'attaquent aux inégalités sociales existantes dans les collectivités affectées de façon disproportionnée par la pandémie de COVID-19.
The 2020 TD Ready Challenge awards $10 million (CDN) in grants to organizations with innovative solutions designed to help address challenges of COVID-19
Press Release
TORONTO, January 29, 2021 /3BL Media/ - Today, TD is proud to award $10 million (CDN) in grants to 15 North American organizations that are working to help address existing social inequities in communities that have been disproportionately impacted by COVID-19.
Leveraging smart infrastructure to enable data-driven utility operations has long been a work in progress, and advancement has been uneven. While many utilities have access to vast amounts of data thanks to deployment of advanced metering infrastructure and sensors across new and legacy assets, only a few early adopters have operationalized the data in a significant way.
Despite decades of progress in reducing hunger, the trend has reversed, and the world is not on track to achieve Sustainable Development Goal (SDG) 2: Zero Hunger by 2030. According to a 2020 United Nations report, nearly 690 million people—60 million more than in 2015 and an estimated 8.9 percent of the world’s total population—are hungry.
DENVER, Colo., January 26, 2020 /3BL Media/ – A blockchain project supported by Arrow Electronics has increased revenue for Honduran coffee growers and helped them establish long-term buying relationships.
Access to breakthrough tech remain out of reach for many who stand to benefit most. Something has to change.
Summary:
Tracey D. Brown, who lives with type 2 diabetes, is CEO of the American Diabetes Association, the nation's largest voluntary health organization and a global authority on diabetes. Jared Watkin is Senior Vice President, Diabetes Care, at Abbott, a leading global health technology company. Their op-ed, republished here, originally appeared in the Boston Herald.
Article
Tracey D. Brown, who lives with type 2 diabetes, is CEO of the American Diabetes Association, the nation's largest voluntary health organization and a global authority on diabetes. Jared Watkin is Senior Vice President, Diabetes Care, at Abbott, a leading global health technology company. Their op-ed, republished here, originally appeared in the Boston Herald.
